ЛАДЕЛЬ, Кристоф, Х. (DE),ГЮРИНГ, Ханс (DE),ЖИГУ, Анна (DE),БРЕННАЙС, Кристиан (DE)
申请号：
RU2018108592
公开号：
RU2018108592A
申请日:
2016.08.11
申请国别(地区):
RU
年份:
2019
代理人:
摘要：
The present invention relates to the use of an FGF-18 compound in combination with a further active ingredient, selected from the group of an inhibitor of IL-6, an inhibitor of IL-6 receptor, an inhibitor of NGF or a botulinum toxin compound. Said composition can be used for the treatment of a cartilage disorder such as osteoarthritis or cartilage injury.
